PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 20260 citationsOpen Access

Association between socioeconomic conditions and biologic prescriptions for inflammatory bowel diseases in Brazil

View Full Paper
CCCaroline CastroLOLuciane OliveiraCSCarlos Roberto Praxedes dos Santos

Key Points

  • The central aim is to investigate how socioeconomic conditions impact the prescription of biologics for inflammatory bowel diseases in Brazil.
  • Analyzed data from healthcare records and socioeconomic surveys.
  • Focused on the prescription patterns of biologics for inflammatory bowel diseases.
  • Performed statistical analyses to determine associations.
  • Higher socioeconomic status correlates with increased rates of biologic prescriptions for inflammatory bowel diseases.
  • Disparities exist in treatment access based on income levels.
  • Findings highlight the need for policies to improve access to biologics in lower socioeconomic groups.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Castro et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875e68https://doi.org/10.35259/isi.2026_76192
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biologic therapy patterns in pregnant women with inflammatory bowel disease in Brazil2026
  2. 2Analysis of IBD Biologics public use with active Bio-Manguinhos/Fiocruz Productive Development Partnerships agreements (2018-2022)2026
  3. 3Hospitalization rate for ulcerative colitis and Crohn’s disease in Brazil and its correlation with socioeconomic inequalities2026
  4. 4Clinical and familial determinants of Post-COVID condition in a brazilian case-control study2026
  5. 5Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance?2025